Immune-related adverse events after 2 years in patients with advanced non-small-cell lung cancer receiving extended immune checkpoint inhibitor therapy.

被引：0
|
作者：
Elghawy, Omar
Barsouk, Adam
Sussman, Jonathan Henry
Davella, Christopher
Singh, Aditi Puri
Ciunci, Christine Agnes
Robinson, Kyle William
Kosteva, John A.
Langer, Corey J.
Cohen, Roger B.
Aggarwal, Charu
Marmarelis, Melina Elpi
Sun, Lova
机构：
[1] Penn Med Abramson Canc Ctr, Philadelphia, PA USA
[2] Univ Penn, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8551
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Longitudinal Immune and Genomic Monitoring Reveals Signatures of Immune-related Adverse Events in Cancer Patients Receiving Checkpoint Inhibitor Therapy
    Khan, Shaheen
    Moses, Angela
    Imam, Marjaan
    Wakeland, Edward K.
    Arana, Carlos
    Fattah, Farjana
    Li, Quan-Zhen
    von Itzstein, Mitch
    Hsieh, David
    Popat, Vinitha
    Barnes, Spencer
    Xie, Yang
    Khan, Saad
    Gerber, David
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [22] Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab
    Toi, Yukihiro
    Sugawara, Shunichi
    Kawashima, Yosuke
    Aiba, Tomoiki
    Kawana, Sachiko
    Saito, Ryohei
    Tsurumi, Kyoji
    Suzuki, Kana
    Shimizu, Hisashi
    Sugisaka, Jun
    Ono, Hirotaka
    Domeki, Yutaka
    Terayama, Keisuke
    Nakamura, Atsushi
    Yamanda, Shinsuke
    Kimura, Yuichiro
    Honda, Yoshihiro
    ONCOLOGIST, 2018, 23 (11): : 1358 - 1365
  • [23] Frequency and clinical significance of immune-related adverse events in non-small-cell lung cancer
    Daniello, L.
    Bozorgmehr, F.
    Kuon, J.
    Gaissmaier, L.
    Kirchner, M.
    Elshiaty, M.
    Diekmann, L.
    Schneider, M.
    Liersch, S.
    Heussel, C. P.
    Winter, H.
    Herth, F.
    Elshafie, R.
    Muley, T.
    Senghas, K.
    Meister, M.
    Kriegsmann, K.
    Benesova, K.
    Kriegsmann, M.
    Bischoff, H.
    Stenzinger, A.
    Thomas, M.
    Christopoulos, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 147 - 147
  • [24] Association Between the Severity of Immune-related Adverse Events and the Prognosis in Patients With Non-small Cell Lung Cancer Receiving Treatment With Immune Checkpoint Inhibitors
    Inomata, Minehiko
    Matsumoto, Masahiro
    Hayashi, Kana
    Seto, Zenta
    Hirai, Takahiro
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Imanishi, Shingo
    Miwa, Toshiro
    Hayashi, Ryuji
    Matsui, Shoko
    Tobe, Kazuyuki
    ANTICANCER RESEARCH, 2023, 43 (07) : 3241 - 3246
  • [25] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [26] Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients
    Remon, Jordi
    Mezquita, Laura
    Corral, Jesus
    Vilarino, Noelia
    Reguart, Noemi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1516 - S1533
  • [27] Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer
    Raynes, George
    Stares, Mark
    Low, Samantha
    Haron, Dhania
    Sarwar, Hussain
    Abhi, Dhruv
    Barrie, Colin
    Laird, Barry
    Phillips, Iain
    Mackean, Melanie
    CANCERS, 2023, 15 (23)
  • [28] Incidence and Timing of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor as Monotherapy or in Combination With Chemotherapy
    Secor, A.
    Zhao, S.
    Wei, L.
    Das, P.
    Haddad, T.
    Miah, A.
    Spakowicz, D.
    Lopez, G.
    Husain, M.
    Grogan, M.
    Li, M.
    Schweitzer, C.
    Pilcher, C.
    Uribe, D.
    Cheng, G.
    Phelps, M.
    Guo, J.
    Shields, P.
    He, K.
    Bertino, E.
    Carbone, D.
    Otterson, G.
    Presley, C. J.
    Owen, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E21 - E21
  • [29] Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
    Durbin, Sienna M.
    Zubiri, Leyre
    Perlman, Katherine
    Wu, Chia-Yun
    Lim, Tristan
    Grealish, Kelley
    Hathaway, Nora
    Lopiccolo, Jaclyn
    Wang, Mike
    Falade, Ayo
    Molina, Gabriel
    Jacoby, Ted Victor
    Shah, Nishi
    Mooradian, Meghan J.
    Reynolds, Kerry L.
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [30] Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
    Shao, Jun
    Wang, Chengdi
    Ren, Pengwei
    Jiang, Yuting
    Tian, Panwen
    Li, Weimin
    BIOSCIENCE REPORTS, 2020, 40
12345